Hansoh Pharmaceutical Group

Latest news

• 翰森製藥(3692)歐盟撤銷阿美樂替尼上市許可 強調屬程序問題並計劃盡快重新申請 (opens in a new tab)

  Minichart · Sep 27, 2026

• Hansoh Pharmaceutical Group Co Ltd's Dividend Analysis (opens in a new tab)

  GuruFocus.com · Sep 22, 2026

• Sector Update: Healthcare Stocks Gain Late Afternoon (opens in a new tab)

  MT Newswires · Jul 28, 2026

• 
  Fresh off buyout, Akero execs reunite to advance long-acting psoriasis pill (opens in a new tab)

  BioPharma Dive · Jul 14, 2026

• GSK plans to sell chronic hepatitis B drug in China through Sino Biopharm (opens in a new tab)

  May 11, 2026

• 
  GSK's Risvutatug Rezetecan Gets Japan Orphan Drug Tag for Lung Cancer (opens in a new tab)

  Zacks · Mar 23, 2026

• 
  Olatorepatide Obesity Treatment Licensed by Regeneron Demonstrates Positive Phase 3 Results in Chinese Patients (opens in a new tab)

  GlobeNewswire · Mar 9, 2026

• 
  Terns Pharmaceuticals (TERN) Valuation Check After Expanded Global Rights To TERN-701 (opens in a new tab)

  Simply Wall St. · Feb 3, 2026

• 
  Terns Pharmaceuticals (TERN) Eyes Expansion Beyond China Amid Strong Analyst Sentiment (opens in a new tab)

  Insider Monkey · Feb 2, 2026